Taubman Institute welcomes new gift officer
The Taubman Institute has a new ally in its quest to support the lifesaving work of U-M’s most promising clinician-scientists.
Maria Muller has been assigned by the university’s office of medical development to serve as the Taubman Institute’s lead development officer. She’ll be working with benefactors and prospective supporters to create giving opportunities that fulfill the aims of donors while underwriting important institute efforts such as the Emerging Scholars Program.
Muller brings a robust background in higher education fundraising. A native of Ohio, she began her development career at Harvard University, shepherding major gifts for Harvard’s business and public health schools, the Kennedy School of Government and the fundraising activities of the university president’s office among others.
Returning to her Midwestern roots, Muller served as a major gifts officer for the U-M College of Engineering, working with alumni and individual supporters, facilitating corporate support of scholarships, internships and other initiatives. But the special rewards and challenges of engaging support for medical research really appeal to her, she says.
“People want to be actively engaged, and at the Taubman Institute we have very special opportunities for that,” Muller said. “There is a way to help our donors be part of the dynamic conversation about healthcare, and to experience the transformative power of individual philanthropy -- right here where we are aggressively working to save people. For a development officer, that’s rarefied air.”
“We are delighted, and very fortunate, to have Maria as our colleague and champion,” said Taubman Institute Director Eva L. Feldman, M.D., Ph.D. “The scholars and I, along with Mr. Taubman, are very impressed by her acumen, energy and enthusiasm. I know our generous supporters will greatly enjoy working with her.”
Taubman-sponsored research offers breast tumor insights
Taubman Emerging Scholar Dr. Scott Tomlins has authored a new study about phyllodes tumors.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
Familial ALS affects generations
Detroit News column featuring Dr. Eva Feldman depicts the toll of the disease on one Metro Detroit family
news & events
In the News
PBS series features institute director on Jan. 18
"The Embrace of Aging," a documentary series airing Sundays at 2:30 p.m. on Detroit Public Televsion, features Taubman Institute Director Eva Feldman, M.D., Ph.D. and her landmark ALS stem cell trial in the Jan. 18 episode.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.